The introduction of nicotinamide to be a nicotine alternative in e-cigarette and smokeless products and solutions represents a major regulatory obstacle for that FDA. Nicotinamide doesn't have nicotinic receptor agonist activity and is known to work as a sedative at large dosages6. The promises made by Nicotine River, ECBlend, and other vendors tha